Ignite Creation Date:
2024-05-06 @ 7:57 PM
Last Modification Date:
2024-10-26 @ 3:17 PM
Study NCT ID:
NCT06191848
Status:
RECRUITING
Last Update Posted:
2024-01-16
First Post:
2023-12-18
Brief Title:
Subcutaneous Tirzepatide Once-weekly in Patients With Obesity and Knee Osteoarthritis STOP KNEE-OA
Sponsor:
University of Melbourne
Organization:
University of Melbourne
Study Overview
Official Title:
Effect of Subcutaneous Tirzepatide Once-weekly in Patients With Obesity and Knee Osteoarthritis STOP KNEE-OA A Randomized Double-Blind Placebo-Controlled Trial
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
STOP KNEE-OA
Brief Summary:
This is a trial of tirzepatide in people with obesity and knee osteoarthritis The main purpose of this study is to see if tirzepatide can reduce number of these participants who require a knee replacement Participants will be randomized to take a weekly injection of tirzepatide or a placebo for a total of 72 weeks
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?:
None